Extranodal marginal zone B-cell lymphoma of the lung: experience with fludarabine and mitoxantrone-containing regimens (Q38065131)

28 August 2017

title

Extranodal marginal zone B-cell lymphoma of the lung: experience with fludarabine and mitoxantrone-containing regimens (English)

1 reference

marginal zone B-cell lymphoma

28 August 2017

1 reference

1 reference

Pier Luigi Zinzani

1 reference

28 August 2017

Enrico Derenzini

0 references

Venerino Poletti

0 references

Lisa Argnani

0 references

Michele Baccarani

1 reference

28 August 2017

Stefano Pileri

1 reference

28 August 2017

Cinzia Pellegrini

1 reference

28 August 2017

Letizia Gandolfi

1 reference

28 August 2017

Beatrice Casadei

1 reference

28 August 2017

Alessandro Broccoli

1 reference

28 August 2017

Federica Quirini

1 reference

28 August 2017

Monica Celli

1 reference

28 August 2017

Stefano Fanti

1 reference

28 August 2017

Vittorio Stefoni

1 reference

28 August 2017

language of work or name

1 reference

5 December 2012

1 reference

28 August 2017

published in

Hematological Oncology

1 reference

28 August 2017

1 reference

28 August 2017

1 reference

28 August 2017

page(s)

183-188

1 reference

Low-grade B-cell bronchial associated lymphoid tissue (BALT) lymphoma

28 August 2017

cites work

1 reference

Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare disease

21 January 2018

1 reference

Extranodal marginal zone B-cell lymphoma of MALT-type of the lung: single-center experience with 12 patients

21 January 2018

1 reference

Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue

21 January 2018

1 reference

Prolonged clinical remission in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type treated with cladribine: 6 year follow-up of a phase II trial.

21 January 2018

1 reference

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

21 January 2018

1 reference

Revised response criteria for malignant lymphoma

21 January 2018

1 reference

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental H

21 January 2018

1 reference

Pulmonary marginal zone B-cell lymphoma of MALT type--what is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) study.

21 January 2018

1 reference

Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type

21 January 2018

1 reference

Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma

21 January 2018

1 reference

Regression of pulmonary MALT lymphoma after treatment with rituximab.

21 January 2018

1 reference

A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas

21 January 2018

1 reference

Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type

21 January 2018

1 reference

Non-gastric marginal zone B cell lymphoma: clinicopathologic features and treatment results

21 January 2018

1 reference

18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma

21 January 2018

1 reference

Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients

21 January 2018

1 reference

Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma

21 January 2018

1 reference

7 January 2021

Primary pulmonary lymphomas. A clinical study of 70 cases in nonimmunocompromised patients

1 reference

7 January 2021

Primary non-Hodgkin's lymphoma of the lung

1 reference

7 January 2021

Primary lymphomas of the lung: morphological, immunohistochemical and clinical features

1 reference

7 January 2021

Pulmonary malignant lymphoma of mucosa-associated lymphoid tissue (MALT) arising in a pediatric HIV-positive patient

1 reference

7 January 2021

Lymphoma of bronchus-associated lymphoid tissue

1 reference

7 January 2021

Pathologic and clinical features of primary pulmonary extranodal marginal zone B-cell lymphoma of MALT type

1 reference

7 January 2021

Primary pulmonary non‐Hodgkin's lymphomas

1 reference

7 January 2021

Primary non-Hodgkin's lymphoma and pseudolymphoma of lung: a study of 161 patients

1 reference

7 January 2021

PULMONARY MALIGNANT LYMPHOMAS AND PSEUDOLYMPHOMAS: CLASSIFICATION, THERAPY, AND PROGNOSIS

1 reference

7 January 2021

Pulmonary lymphomas and other pulmonary lymphoid lesions. A clinicopathologic and immunologic study of 64 patients

1 reference

7 January 2021

Primary pulmonary lymphoma

1 reference

7 January 2021

90Y-ibritumomab tiuxetan (Zevalin) in heavily pretreated patients with mucosa associated lymphoid tissue lymphoma

1 reference

7 January 2021

Identifiers

DOI

10.1002/HON.2039

1 reference

release_2rgrjhpyxfgpfci53xk7pdtuu4

28 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2rgrjhpyxfgpfci53xk7pdtuu4

24 November 2022

mapped directly with Wikidata item

1 reference